GamaMabs Pharma Competitors and Similar CompaniesClear all

GamaMabs Pharma's competitors and similar companies include Ikena Oncology, Dendreon and Seagen.

	GamaMabs Pharma GamaMabs Pharma is a clinical-stage immuno-oncology company.	Ikena Oncology Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment.	Dendreon Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy.	Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
Founding Date	Founding Date 2013	Founding Date 2016	Founding Date 1992	Founding Date 1998
Type	Type Private	Type Public	Type Subsidiary	Type Subsidiary
Tags	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy
Locations	Locations Toulouse, FR HQ	Locations Boston, US HQ	Locations Seal Beach, US HQ Seattle, US Union City, US Tampa, US	Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more
Employees	Employees N/A	Employees 5052% increase	Employees 6131% decrease	Employees 3,25622% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $800k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $2b (FY, 2022)
Net income	Net income N/A	Net income ($45.3m) (FY, 2025)	Net income N/A	Net income ($610.3m) (FY, 2022)
Funding
Total funding raised	Total funding raised $ 20.5m	Total funding raised $ 49m	Total funding raised N/A	Total funding raised $ 164m